is caused by pregnancy llnd is not cured until the patient is delivered. The differences in the pathogenesis and natural history of these two eonditions dictate that the approach to their management should be different and, therefore. every attempt should be made to differentiate these two conditions. This is usually possible if an accurate medical history is available and if the patient is seen in early pregnancy and a careFul examination is done at that time.
A patient with history of hypertension and/or renal Abstract Hypertensive disorders of prugmmcy are re;ponsiblc for a significant proportion of maternal and perinatal deaths. This group of disorders include the specific hypertensive disease of pregnancy; preeclampsia/eclampsia, a,s well a.s chronic hypertensive disease antedating pregnancy 'vith or without superimposition of preeclanlpsiaJeclampsia. The natural course and management of the.-.e 2 distinct entities are different, ilnd lherefore every attempt should be made to make the correct diagnosis. The differential diagnosis depends on accurate history and physical examination, a~well a.~hiochemical te<>ts, specifically Serum uric add. The~reatment of chronic hypertensive disease is outlined. with emphasis on the indicat ions for antihypertensive llledieatiolls, dose monitoring of the feto-placental unit, and timing of deli very. The m a nagem ent () f the severe cases (hypertensive crisis and/or severe supe::impsoed preeclampsia) is also discussed.
Key WOTdP regnancy. hypertensive disorders, chronic hypertensi ve disease. preecl ampsia/ ecl am psi a, superi mposed preedamp~ia/eclanrpsia, different ill! diagnosis, management, hyperuricemia. an t ihypertensives. Introduction H)11crtensive r1isorders complicate 5-10% of all pregnancies. TIlese indude the s~~ific hypertensive di.'\("a.~e of rregmmcy. i.e., preeclampsia/eclampsia aw ell as case) of chronic hypertensive diseHse of various etiologies antcclatin14 the pregnancy. It is clear that the.'e disease enlitie~differ in pathogenesis and pathology but still they share a similar dinical picture characterized by hypertension. edema, and/or proteinuria. Hypertension is defined as an increase in the systolic pressure~30 torr and/or the diastolic pressure by~15 torr over nonpregnant or early pregnant levels measured twice at lea. . . .t 6 hours apart. Proteinuria is defined a~urinary excretion of protein in excess of 0.3 gIL in H 24 hour sample or in excess of 1 giL in a random sample. Edema is defined a~a rapid increase in ',\.'eight. that is, > lIb/week.
The commonly accepted classificat.ion of these hypertensive disorders is that of thp. A specific biochemical test that in the author's experience was found to be very helpful in the differential diagnosis is serum uric acid (SUA). In chronic hYlJertemive or renal disease SUA is usually normal or slightly elevated. Tn the more severe cases SUA wul be increased. but proprotionately to the increase of other nitrogenous end products, i.e., creatinine and blood urea nitrogen (BUN). Onlhe other hand in preeclampsiu, there is hyperuricemia in the absence of elevation of the other nitrogenous end products. Otherwise, SUA v,,;ll be increased relatively more than the increase in BUN and creatinine. 2 One must remember lhat in interpreting these tests, that SUA, BUN and creatinine levels are normally decreasd during pregnancy. Thid ecrease results from the increased clearances of these substances and the hemodilution of pregnancy. Other biochemical tests are nol that helpful; for example, creatinine clearance is impaired in both preeclampsia, and cnwnic hypertensive di.o;ease. 2 3 A definite diagnosis can only be reached by pathological examination of renal biopsies; patient.~\ \-'ith preeclampsia ""'ill have a characteristic g10mcnllar lesion described as glomerular capiJlary endotheliosis,~while other renal lesions will be seen in other entities. l Renal biopsy, howver, i.~reserved for those cases in which renal disease is strongly suspected and in which t.he determination of il~nature will influence the specific management. FinaUy, 6 weeks postparhlm, all preeclamptic patients should be normotensive, whereas the majority of patients with chronic hypertension will still be hypertensive; the others will be normotensive, only to hecome hypertensive again in a follOWing pregnancy.
Management
Pat ients with mild hypertension that was \Int reated prior to pregnancy usuaUy perform very well. I n only a small proportion of these patients, hy-pertension will be exacerbated during pregnancy and they will require the institution of antihypertensive therapy. The fetal mortality (1.7 %) i.~only~lightly higher than in the general population. Howe....er, there may be an increase in the incidence of fetal growth retardation (secondary to placental insufficiency). In all palients requiring antihypertensive therapy, manage01ent shouJd also include evaluation of fetal growth by ultrasonography and evaluation of fetal well-being beginni.ng at .'32-34 weeks, ulilizing any or all of tht' avail<lble tests, that is, nonst rpx~test's (NST). (.'(mtraclion st ress test.~(CST). and estriol (E J ). Spontaneous onset of labor is usually awaited unless there il\ evidence of fetal jeopardy which will indicate induclion of la bar.Õ n tbe other hand, patienl~with severe hypertension are definitely at an increased risk. The fetal death rate has been reported to be 23 %, and the maternal mortality rate to be approximately 1 %. due to cercbrova..;cular accidents and/or heart failure. Those patients with moderate to severe hypertension who were treated prior to pregnancy shou.ld be continued on antihypertensive therapy. We would discontinue diuretic therapy if that has been used. Patients with chronic hypertensive di..;easc du not increase their plasma volume as do normal pregnant wumen and diuretic therapy may exaggerate this ahnormality. Their use may further reduce a compromised placental circulation especially if sodium intake has been restricted.
B Ordinarily we use methyldopa and/or hydralazine even jf t.he patient ha.., been using other dru~. The usual daily dose is 1-2 g of methyldopa (maximum of .3 g), and 50-200 mg of aprcsolinc, orally. On the other hand, other authors ha....e allowed their patients to continue diuretic therapy 7 R and may also allow their patients to use other antihypertensive dmgs, for example, propranolol or other B-blockers, such as metoprololo and oxprcnolol. 'o The mechanisms of action. benefits, problems, indicatiom, and description of the different regimens of antihypcrten~ive tllcrapy during pregnancy are beyond the scope of this article and have been reviewed recently. 1 
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In addition, these patients should bc enL'Ouraged to
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rt~dIJL'e their activity and to have adequate bedre.'it.
They wi II rcC') uire frequent ho~pital ization to stabil ize their blood pres:;un.: and to evalllatp. their kidney function. Ft.,tal growth shonld be evaluated with ultra!'onography, and (ctal well-being should be monitored closely with NST, CST. and E and, if in the more sevae ('a.~e:s when the need to deliver is urgeTlt and specially in pretenll preglll.lndes when the cervix is mo.~lly unfavorahle,~esareall section is the melhod of clioict.. 5 [n inst,tn~where hyperten.sive d~t"rL~e i.s worsening. i.e .. umtahl increasin),', blood pr sure despite fnll therapeutic dos 
fluid replacement is an important component of 2. Sodium nitroprusside: This is another very potent therapy; replacement could be by either .5% dextrose \'a~dilator with almost instant action. It causes a in one-half normal saline. balanced salt solution, predictable and cort.<;i.~tent fall in blood pressure.
plasminate. saIt free albumin, or blood, in ca.o.c of Nitroprusside in uniquely specific for vascular blood loss. Hoever, care should be exercised not tu receptors and dilates both resistance and overload the circulation because the infusion is carried capacitance blood ve.<;sek It has no effect on the in the face of a contractoo vascular bed (generalized beart or autonomic ncrve Ct:nters. No change in arteriolar vasospasm). Hence. it i~imperative to uterine blood flow has been observed in eit.hcr nOfmonitor the central circulation in tht.'Se patients. In motensive or hypcrtemive slecp.a Its aLtion i~rcadi-most instances, a central venous pressure catheter is Iy reversible once the aclministrntion is disconprobably adequate. but in the more severe cases. a tinued. A solution containing 100 JlglmL of sodium balloon flotation (Swan-Ganz) catheter pa~ed into the nitroprusside is infused intravenously at a dose of pulmonary artery t'i advi.sable. This provides for eonapproximately 1 p.g/kgfminute. The rate of infusion tinuolls measurement of pulmonary capillary wedge has to be titrated according to the blood pressure pressure, pulmonary artery pressure, left ventricular response. The container and the inlravenou.'i tubing end diastolic pressure, pulmonary alld Iota.! peripheral should be covered. became the drug i.~light sen-\'asl:ulur resistances, and cardiac output. IJ A consitive. This drug is metabolized by the liver to thiocomitantly insertcd ;lrteria! line will provide for nccyanate. It crosses the placenta and corresponding, curnte monitoring of arterial hlood pressure, arterial or higher. blood levels are achieved in the fetus.
blood gases, and pH. This is a major concern, because the fetal liver may I n a previous stllUY, we fouTid a tendency to nut be as capable of metabolozing nitroprusside as metabolic acidosis in severe preeclampsia." SodiuOl the adult liver and the danger of fetal cyanide toxbicarbonate therapy may be mX.. ·essary to corn~d their icity exists even in an asymptomatic mother.
acidosis. Morcover. in severely preeclamptic palienl'i with D. Anticonvulsanl'i marked impairment of hepatic function, maternal
In the United States. magnesium sulfate (MgS04 ) is cyanide toxicity is a potential danger, which has the drug of choice for the management of severe (inlimited nitroprlls.~ide usc in these patienbi. It should eluding superimposed) preeclampsia/eclampsia. The only he used to control hlood pressure in cast: of an drug has a eurarelikc aelion on the neuromuscular acute hypertensive crisis that is unresponsive to junction, decreasing the amount of acetylcholine diazoxirle or hydralizine. and toe patient should be liberated by t.he nerve impulses. I n addition, it reduces delivered as quickly as possible thereafter.
B the excitability of the cerebral cortex, raising the B. Diuretics threshold for convulsions. MgSO. is a very effective anThe use of diureties in the management of these ticonvulsant, and it is very r;lre (2-4 %) that eclamptic patients is generally considered inadvisable, convulsions will or recur when it i~given in propcr becau.~e these palients arc already hypovolemic. In dosage. MgSO. when given as an intravenou.s bolus patients with oliguria, correction of the fluid will calise a moderate but transient drop in blood balance (volume deficits) usually results in increase pressure. probably due to peripheral vasodilation. It in urinary output. If not, urgent delivery is proalso has a slight diuretic effect. probahly due to bably safer than repeated administration of manvasodilation of the glomerular afferent arterioles. nitl1l or furosemide (Lasix), However, diuretics arc Studies in the monkey have shown a significent inindieated when there is impending left heart failure crease in uterine blood flo,,\,. but it is not kno\\>u if a or for the treatment of acute pulmonary edema. In similar effect is produL-ed in humans. 11 Initially. lO-20 these situations. Lasix, given as 20-40 mg inmL of 20% solution, thaJ is, a 2-4 g of MgSO. is adtTavenous boluses. is the drug of choice. Its adrnini..~teJ'(:d intravenou.sly over a 5--1.') minute period. In rnini.stration and tbe rate of infusion of colloid or our institution and at most centers, this bolus is followcrystalloid solutions should be monitored closely, cd by a continuolls intravenous inflL~ion of MgSO. at preferably with a balloon notation (Swan-Gal1Z) the rate of 1-2 gfhour. On the other hand. Pritchard catheter (See below). Certain precautions have to be taken to uvuid magnesium toxicity; (a) The deep tendon reflexes should be checked hourly with intravenous infusion or before the subsequent intramuscular dose. (b) The respiratury rate should not be lesx than 12/minute. (c) Urine output should not be less than 25-30 mLJhour. In hospitals where blood magnesium levels can be easily obtained, these should be monitored periodically.
The antidote for magnesium, that is, calcium, should be readily available at all times. Ten milllJiters of 10 % calcium chloride or gluconatc would qnickly reverse mal:,rnesi urn toxicity.
Several other drug regimens have been advocated [rom time to time, and some arc still u.o;ed in othl'r parts of the world. At pre;cnl, diazepam (Valium) is probably the most commonly used drug outside the United States.l~However, MgSO. hus been used over the years in this (:Dunlry with such good rcsu.lts (maternal mortality of 0% in la.rge reported series)'S that obstetriciam, in general. do lIot foresee any benefits to be derived frum switching to other regimens. The management of eclampsia is beyono the st.'Ope of thi.o; article clOd is discussed eJ.o;ewhere.
